Accepting New Patients
Arsen Osipov, MD
Fax: 424-314-8777
From You
4.9
4.9
Languages
- Armenian,
- English,
Gender
Male
Locations
Samuel Oschin Cancer Center
Samuel Oschin Cancer Center
-
Self-parking is available in Cedars-Sinai parking lot P4. The cost is: 1st hour free, $5 each hour thereafter and $15 daily maximum. Valet parking is the same price as self-parking. Gratuities are not accepted. Valet is available at lot P4 Pavilion M-F, 5 a.m.-10 p.m.
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- IM Hematology Oncology
Programs
Cedars-Sinai clinical programs this provider is part of:
6
Research Areas
Titles
- Assistant Professor, Medicine
Education & Training
-
Johns Hopkins University, School of Medicine
Fellowship - Completed 2020
-
Cedars-Sinai Medical Center
Residency - Completed 2017
-
Virginia Commonwealth University School of Medicine
Degrees - Completed 2013
Achievements
-
2
Board Certifications
-
13
Awards and Honors
Board Certifications
-
IM/Oncology
American Board of Internal Medicine
-
General Internal Medicine
American Board of Internal Medicine
Awards and Honors
- Leo Rigler Award for Academic Achievement “Resident of the Year 2016”, Cedars-Sinai
- ASCO/AACR, Workshop on Methods in Clinical Cancer Research Workshop
- PHASE ONE Young Investigator Award for Cancer Translation
- VCU School of Medicine, Dean’s Merit Scholarship
- Health Sciences Assistant Professor, UCLA
- ASCO Conquer Cancer Foundation, Young Investigator Award
- Chief Resident, Internal Medicine, Cedars-Sinai & Greater Los Angeles (GLA) Veterans Administration, Los Angeles, CA
- Resident of the Year, 1st Year Resident Award, Saban Community Clinic
- NIH K08 Clinical Scientist Research Career Development Award
- Adjunct Assistant Professor, Johns Hopkins University
- Chief Medical Oncology Fellow, Medical Oncology, Johns Hopkins University, School of Medicine, Baltimore, MD
- Recipient of Linda Rubin Fellowship in Pancreas and GI Oncology Research Endowment, Johns Hopkins University
- ASCO Conquer Cancer Foundation, Career Development Award 2021
Publications
- Osipov A, Lim SJ, Popovic A, et al. Tumor Mutational Burden, Toxicity and Response of Immune Checkpoint Inhibitors (ICIs) Targeting PD(L)1, CTLA-4, and Combination: A Meta-Regression Analysis [published online ahead of print, 2020 Jun 25]. Clin Cancer Res. 2020;clincanres.0458.2020. doi:10.1158/1078 0432.CCR-20-0458
- Osipov A, Murphy A, Zheng L. From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy. Adv Cancer Res. 2019;143:63 144. doi:10.1016/bs.acr.2019.03.002
- Osipov A, Naziri J, Hendifar A, et al. Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy. J Gastrointest Oncol. 2016;7(2):239-247. doi:10.3978/j.issn.2078-6891.2015.109
- Osipov A, Nissen N, Rutgers J, et al. Redefining the Positive Margin in Pancreatic Cancer: Impact on Patterns of Failure, Long-Term Survival and Adjuvant Therapy. Ann Surg Oncol. 2017;24(12):3674-3682. doi:10.1245/s10434-017-6076-z
- Osipov A, Zaidi N, Laheru DA. Dual Checkpoint Inhibition in Pancreatic Cancer: Revealing the Limitations of Synergy and the Potential of Novel Combinations [published online ahead of print, 2019 Jul 18]. JAMA Oncol. 2019;10.1001/jamaoncol.2019.1583. doi:10.1001/jamaoncol.2019.1583
- Tuli R, Shiao SL, Nissen N, Tighiouart M, Kim S, Osipov A, et al. A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer. EBioMedicine. 2019;40:375-381. doi:10.1016/j.ebiom.2018.12.060
- Osipov A, Blair AB, Liberto J, Wang J, Li K, Herbst B, Xu Y, Li S, Niu N, Rashid R, Ding D, Liu Y, Wang Z, Wolfgang CL, Burkhart RA, Laheru D, Zheng L. Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells. Cancer Biol Med. 2021 Feb 15;18(1):206-214. doi: 10.20892/j.issn.2095-3941.2020.0273. PMID: 33628595; PMCID: PMC7877172.
Insurances
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Cedars-Sinai location or provider is included in your network.